Exact Sciences Corp
(STU:EXK)
€
50.94
-14.13 (-21.72%)
Market Cap: 9.26 Bil
Enterprise Value: 10.85 Bil
PE Ratio: 0
PB Ratio: 3.15
GF Score: 77/100 
Exact Sciences Corp at UBS Global Healthcare Conference Transcript
May 21, 2019 / 06:00PM GMT
Release Date Price:
€87.59
(+2.29%)
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
Great. Welcome. My name is Dan Brennan. I cover tools, diagnostics and pharma services here at UBS. Welcome to the afternoon session with Exact Sciences. To my left, I have Jeff Elliott, Chief Financial Officer.
I have a series of questions prepared, but feel free to time in. I'll look up periodically throughout the presentation.
Before we start, you can go to our website at www.ubs.com and look for analyst disclaimers.
So with that, first of Jeff, thanks for coming.
Jeffrey T. Elliott
Exact Sciences Corporation - CFO
Thank you Dan.
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
I thought, we'd just dive right into Q&A.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers